{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for azelaic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
NCT03541369: Phase 1 Interventional Terminated Relapsed/Refractory Acute Myeloid Leukemia (AML)
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03746431: Phase 1/Phase 2 Interventional Recruiting Advanced Solid Tumours
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04097821: Phase 1/Phase 2 Interventional Completed Myelofibrosis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01405196: Phase 2 Interventional Completed Lupus Erythematosus, Systemic
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01963052: Phase 1 Interventional Completed Metastatic Urothelial Cancer
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03574545: Phase 1 Interventional Completed Rheumatoid Arthritis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01042379: Phase 2 Interventional Recruiting Breast Neoplasms
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04189614: Phase 1 Interventional Active, not recruiting Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
